Posters

Traumatic cataract and intralenticular foreign body

Poster Details

First Author: M.Stamenkovic SERBIA

Co Author(s): V. Lukic   V. Jaksic   S. Babovic   N. Nikitovic   A. Bajic   H. Kujundzic     

Abstract Details

Purpose:

To report clinical evaluation and treatment of two patients with traumatic cataract and intraocular foreign body located in the lens.

Setting:

Eye Clinic, Zvezdara Medical University Center, Belgrade, Serbia

Methods:

Case reportOf all open globe injuries, intraocular foreign bodies (IOFB) are present in 18 to 41% of cases, but only 5-10% are located in the lens. Patients with IOFBs are overwhelmingly male (>90%) with mean age at presentation between 25 and 39 years. We evaluated two patients with intralenticular foreign bodies and traumatic cataracts.

Results:

A 35-year-old male patient presented with a history of trauma to the left eye while hammering metal. Patient`s initial best corrected visual acuity (BCVA) on injuried eye was light perception (LP). Further examination revealed penetrating corneal wound, traumatic cataract and metallic IOFB located in the lens. First, corneal wound was sutured, then IOFB was removed using forceps followed by cataract extraction by phacoemulsification and implantation of posterior chamber intraocular lens (PC IOL). The patient was discharged with visual acuity (VA) 0.4. The second patient also had a penetrating eye injury with metallic intralenticular foreign body. Slit-lamp examination showed full-thickness corneal laceration and total lens opacity. Visual acuity on admission was found to be hand motion. After primary repair of entry wound, combined surgery with IOFB removal, phacoemulsification and PC IOL implantation were performed.

Conclusions:

Traumatic cataracts after penetrating injuries with IOFB located in the lens can be successfully treated with standard phacoemulsification followed by implantation of PC IOL. However, visual outcome depends on several factors which include size, location, material, time of surgical repair and removal of IOFB, as well as development of endophthalmitis.Financial disclosureAuthors declare no financial interest.

Financial Disclosure:

None